1. Home
  2. OMAB vs GKOS Comparison

OMAB vs GKOS Comparison

Compare OMAB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

OMAB

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

HOLD

Current Price

$110.81

Market Cap

5.8B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$108.41

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMAB
GKOS
Founded
1998
1998
Country
Mexico
United States
Employees
N/A
N/A
Industry
Aerospace
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.9B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
OMAB
GKOS
Price
$110.81
$108.41
Analyst Decision
Hold
Strong Buy
Analyst Count
3
14
Target Price
$106.00
$133.07
AVG Volume (30 Days)
71.4K
684.4K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$10.31
$23.39
Revenue Next Year
$12.39
$27.46
P/E Ratio
$21.86
N/A
Revenue Growth
N/A
32.33
52 Week Low
$70.24
$73.16
52 Week High
$134.99
$130.23

Technical Indicators

Market Signals
Indicator
OMAB
GKOS
Relative Strength Index (RSI) 35.22 39.14
Support Level $99.42 $104.72
Resistance Level $111.48 $115.06
Average True Range (ATR) 4.86 4.81
MACD -2.55 -0.91
Stochastic Oscillator 7.84 22.95

Price Performance

Historical Comparison
OMAB
GKOS

About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS

Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: